Anocca AB Licenses Gene Editing Technology from EmendoBio Inc.
SÖDERTÃLJE, Sweden, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Anocca AB, a leading TCR-T1 cell therapy company, today announced the appointment of Martin Welschof to its Board of Directors. ...
SÖDERTALJE, Sweden, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Anocca AB, a leading TCR-T1 cell therapy company, today announced it has received a certificate of good manufacturing practice (GMP)...
S–DERT„LJE, Sweden, May 31, 2023 (GLOBE NEWSWIRE) -- Anocca AB today announces that the company has successfully raised SEK 400 million through an equity financing round led by AMF and...